Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Seda Kilic Erciyas"'
Autor:
Arash Adamnejad Ghafour, Demet Akdeniz Odemis, Seref Bugra Tuncer, Busra Kurt, Mukaddes Avsar Saral, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Betul Celik, Pinar Saip, Hulya Yazici
Publikováno v:
Journal of Ovarian Research, Vol 14, Iss 1, Pp 1-15 (2021)
Abstract The most common gynecologic cancers detected in women in Turkey are uterine cancer, ovarian cancer, and cervical cancer. These data reported that a mean of 3800 individuals were diagnosed with uterine cancer, 2790 were diagnosed with ovarian
Externí odkaz:
https://doaj.org/article/2d639461c5bb4ba083e9ea1a2dc2ae0c
Autor:
Seref Bugra Tuncer, Ozge Sukruoglu Erdogan, Seda Kilic Erciyas, Mukaddes Avsar Saral, Betul Celik, Demet Akdeniz Odemis, Gozde Kuru Turkcan, Hulya Yazici
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-15 (2020)
Abstract Background Ovarian cancer is the second most common gynecologic cancer with high mortality rate and generally diagnosed in advanced stages. The 5-year disease-free survival is below 40%. MicroRNAs, subset of the non-coding RNA molecules, reg
Externí odkaz:
https://doaj.org/article/25ad4afd2c434cb9863a10810f036501
Autor:
Demet Akdeniz Odemis, Betul Celik, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Seref Bugra Tuncer, Busra Kurt Gultaslar, Arash Adamnejad Ghafour, Pinar Saip, Hulya Yazici
Publikováno v:
Turkish Journal of Biochemistry. 47:588-594
Objectives To find BRCA1/2 test selection criteria unique to the Turkish population, as well as to provide the BRCA1/2 gene mutation distributions of patient population to the literature. Methods Genetic counseling was given to 2,373 cases with a fam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ae68ad6c07d5e19d793aee2cd4645f9
https://doi.org/10.1515/tjb-2021-0209
https://doi.org/10.1515/tjb-2021-0209
Autor:
Sevda Ozel, Demet Akdeniz Odemis, Seda Kilic Erciyas, Pinar Saip, Mukaddes Avsar Saral, Hulya Yazici, Seref Bugra Tuncer, Ozge Sukruoglu Erdogan
Publikováno v:
Archives of Gynecology and Obstetrics. 305:193-201
OBJECTIVES Ovarian cancer is one of the most fatal gynecologic malignities. miR-16-5p, miR-17-5p, and miR-638 genes were found to have been associated with ovarian cancer in accordance with the data obtained from the previous microarray research perf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5958b2f117f2119a457ab84eb63176
https://doi.org/10.1007/s00404-021-06138-z
https://doi.org/10.1007/s00404-021-06138-z
Autor:
Demet Akdeniz Odemis, Rejin Kebudi, Seda Kilic Erciyas, Gozde Kuru Turkcan, Seref Tuncer, Ozge Sukruoglu Erdogan, Jamila Bayramova, Betul Celik, Busra Kurt Gultaslar, Sema Büyükkapu Bay, Samuray Tuncer, Hülya Yazici
The aim of the study was to investigate the frequency and types of mutations on the RB1 gene at the familial, clinical, and ethnic levels which are known to have an important role in the genetics of retinoblastoma in Turkish population. RB1 gene muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6920434696cc1db5806c18b185cb303
https://doi.org/10.22541/au.164878743.32929207/v1
https://doi.org/10.22541/au.164878743.32929207/v1
Autor:
Hulya Yazici, Betul Celik, Demet Akdeniz Odemis, Pinar Saip, Seda Kilic Erciyas, Seref Bugra Tuncer, Busra Kurt, Arash Adamnejad Ghafour, Ozge Sukruoglu Erdogan, Mukaddes Avsar Saral
Publikováno v:
Journal of Ovarian Research, Vol 14, Iss 1, Pp 1-15 (2021)
Journal of Ovarian Research
Journal of Ovarian Research
The most common gynecologic cancers detected in women in Turkey are uterine cancer, ovarian cancer, and cervical cancer. These data reported that a mean of 3800 individuals were diagnosed with uterine cancer, 2790 were diagnosed with ovarian cancer,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c0ab5e27b68c0ba58d258138f7e43b
https://doi.org/10.1186/s13048-021-00878-x
https://doi.org/10.1186/s13048-021-00878-x
Autor:
Rejin Kebudi, Demet Akdeniz, Jamila Bayramova, Seda Kilic Erciyas, Gozde Kuru Turkcan, Bugra Seref Tuncer, Ozge Sukruoglu, Betul Celik, Busra Kurt Gultaslar, Sema Bay Buyukkapu, Samuray Tuncer, Hulya Yazici
Publikováno v:
Journal of Clinical Oncology. 40:e22007-e22007
e22007 Background: Retinoblastoma (RB) is the most common intraocular malignancy in children, caused by mutations in the tumor suppressor RB1 gene. Patients with bilateral/trilateral/familial RB are considered to have hereditary RB (1 germline, 1 som
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd41fd419cded8510d1e9892fe65e16b
https://doi.org/10.1200/jco.2022.40.16_suppl.e22007
https://doi.org/10.1200/jco.2022.40.16_suppl.e22007
Autor:
Mukaddes Avsar Saral, Ozge Sukruoglu Erdogan, Seda Kilic Erciyas, Gozde Kuru Turkcan, Demet Akdeniz Odemis, Hulya Yazici, Seref Bugra Tuncer, Betul Celik
Publikováno v:
Journal of Ovarian Research
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-15 (2020)
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-15 (2020)
Background Ovarian cancer is the second most common gynecologic cancer with high mortality rate and generally diagnosed in advanced stages. The 5-year disease-free survival is below 40%. MicroRNAs, subset of the non-coding RNA molecules, regulate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c0a04ce291e804565262c8e63ea758
http://europepmc.org/articles/PMC7453540
http://europepmc.org/articles/PMC7453540
Autor:
Sema Buyukkapu Bay, Samuray Tuncer, Arash Adamnejad Ghafour, Betul Celik, Yasemin Gider, Hulya Yazici, Rejin Kebudi, Khariga Jabbarli, Mukaddes Avsar, Seref Bugra Tuncer, Gozde Kuru Turkcan, Seda Kilic Erciyas, Demet Akdeniz Odemis, Ozge Sukruoglu Erdogan
Publikováno v:
Journal of Oncology, Vol 2020 (2020)
Journal of Oncology
Journal of Oncology
Purpose. Various molecular variations are known to result in different gene variants in the FGFR4 gene, known for its oncogenic transformation activity. The goal of this study was to investigate the FGFR4 p.Gly388Arg variant that plays role in the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8a94e3caa694aa95540afd3f37ec5f2
https://doaj.org/article/392d44460ebb44f890298b6cf4000537
https://doaj.org/article/392d44460ebb44f890298b6cf4000537
Autor:
Secil Demirkol Canli, Ozge Sukruoglu Erdogan, Murat Isbilen, Hulya Yazici, Muhammad Waqas Akbar, Baris Kucukkaraduman, Burçak Vural, Ali O. Gure, Seda Kilic Erciyas, Ege Dedeoğlu
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 4, p e0231835 (2020)
PLoS ONE, Vol 15, Iss 4, p e0231835 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Known risk factors for this disease are currently insufficient in predicting mortality. The only FDA approved prognostic biomarker for PDAC patients is CA19-9. This, along with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c8af01a2a72cc8c842a566792c22d4
https://hdl.handle.net/11693/75674
https://hdl.handle.net/11693/75674